Lakewood-Amedex Biotherapeutics Inc. Common Stock (NASDAQ: LABT) last traded at $0.782, down 1.26% on the session. The quote above updates while this page is open; the figures below are drawn from Lakewood-Amedex Biotherapeutics Inc. Common Stock’s own filings and are restated only when a new one is published.
Lakewood-Amedex Biotherapeutics Inc. Common Stock trades on NASDAQ under the ticker LABT. Its market capitalisation is $1.85 million.
Valuation measures for Lakewood-Amedex Biotherapeutics Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $1.85M |
|---|---|
| Enterprise value | -$102.8K |
| Price / book | 0.43 |
| Beta | -0.84 |
Trailing-twelve-month figures tagged in Lakewood-Amedex Biotherapeutics Inc. Common Stock's XBRL filings with the SEC.
| Net income (TTM) | -$3.85M |
|---|---|
| Return on equity | -88.84% |
| Cash | $2.58M |
Range and volume for LABT over the past 52 weeks.
| 52-week high | $98.20 |
|---|---|
| 52-week low | $0.760 |
| Volume | 118.1K |
| Average volume | 2.46M |
| Previous close | $0.792 |
Invest a chosen dollar amount in Lakewood-Amedex Biotherapeutics Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell LABT.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.